Company
Headquarters: Toronto, ON, Canada
CEO: Mr. Behzad Khosrowshahi C.P.A.
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
| Last Financial Reports Date | Dec. 31, 2023 |
| Revenue TTM | C$227.6 M |
| EBITDA | C$144.2 M |
| Gross Profit TTM | C$0 |
| Profit Margin | 55.51% |
| Operating Margin | 49.74% |
| Quarterly Revenue Growth | 235.00% |
DRI Healthcare Trust has the following listings and related stock indices.
Stock: TSX: DHT.UN wb_incandescent